Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcome.
Tom ClaeysCharles Van PraetNicolaas LumenPiet OstValérie FonteyneGert De MeerleerBieke LambertLouke DelruePieter De VisschereGeert VilleirsKarel DecaesteckerPublished in: BioMed research international (2015)
SLND is feasible, but postoperative complication rate seems higher than that for primary LND. Biochemical and clinical response duration is limited, but as part of an oligometastatic treatment regime it can defer palliative ADT.